Ameritas Investment Partners’s Praxis Precision Medicines PRAX Stock Holding History

Ameritas Investment Partners’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$764K	Buy	2,281 +168	+8%	+$53.2K	0.02%	733
2026 Q1	$681K	Buy	2,113 +247	+13%	+$76.4K	0.02%	741
2025 Q4	$550K	Buy	1,866 +347	+23%	+$64.6K	0.02%	804
2025 Q3	$80.5K	Sell	1,519 -170	-10%	-$8.24K	﹤0.01%	1819
2025 Q2	$71K	Hold	1,689	–	–	﹤0.01%	1962
2025 Q1	$64K	Hold	1,689	–	–	﹤0.01%	1973
2024 Q4	$130K	Hold	1,689	–	–	﹤0.01%	1610
2024 Q3	$97.2K	Hold	1,689	–	–	﹤0.01%	1811
2024 Q2	$69.9K	Buy	+1,689	New	+$79.8K	﹤0.01%	1955
2023 Q2	–	Sell	-166	Closed	-$2.01K	–	3187
2023 Q1	$2.01K	Hold	166	–	–	﹤0.01%	2958
2022 Q4	$10.2K	Hold	166	–	–	﹤0.01%	2803
2022 Q3	$5K	Hold	166	–	–	﹤0.01%	2926
2022 Q2	$6K	Hold	166	–	–	﹤0.01%	2940
2022 Q1	$25K	Hold	166	–	–	﹤0.01%	2464
2021 Q4	$49K	Hold	166	–	–	﹤0.01%	2148
2021 Q3	$46K	Buy	166 +39	+31%	+$10.6K	﹤0.01%	2222
2021 Q2	$35K	Buy	127 +65	+105%	+$23.3K	﹤0.01%	2419
2021 Q1	$30K	Hold	62	–	–	﹤0.01%	2382
2020 Q4	$51K	Buy	+62	New	+$36.2K	﹤0.01%	1986

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ameritas Investment Partners's PRAX Position: Q2 2026 in Review

Ameritas Investment Partners increased its Praxis Precision Medicines (PRAX) stake by 8% in Q2 2026, buying an estimated $53.2K and bringing the position to 2,281 shares worth $764K. The position accounts for 0.02% of the portfolio, ranked #733.

Ameritas Investment Partners first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Ameritas Investment Partners held 2,281 shares of Praxis Precision Medicines worth $764K as of Q2 2026.
Ameritas Investment Partners bought 168 Praxis Precision Medicines shares in Q2 2026, an estimated $53.2K.
Praxis Precision Medicines made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #733 holding.
Ameritas Investment Partners first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.